Aberdeen, Scotland, United Kingdom Grampian Biopartners appeared to be the VC, which was created in 2008. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Aberdeen.
Among the most successful fund investment fields, there are Therapeutics, Clinical Trials. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight NovaBiotics. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Grampian Biopartners, startups are often financed by Woodford Investment Management, Tweed Renaissance Investors Capital, Aurora Private Equity. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Tweed Renaissance Investors Capital.
The top activity for fund was in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Asia Summit Capital | China, Hong Kong, Hong Kong Island |
| Canon Medical Systems | Japan, Ohtawara, Tochigi Prefecture |
| China Renaissance Group's Healthcare Fund. | - |
| CultuurInvest | - |
| Florac | France, Ile-de-France, Paris |
| Granite State Angels | Hanover, New Hampshire, United States |
| Huaxu Capital | - |
| Jiuli Jijin | China, Minhang, Shanghai |
| Portico Ventures | - |
| RFI Advisors | Japan, Tokyo |
| RIME Communications Capital | New York, Roslyn Heights, United States |
| Thornton Tomasetti | New York, New York, United States |
| Tower Three Partners | Connecticut, Greenwich, United States |
| UPMC | Pennsylvania, Pittsburgh, United States |
| Zhejiang Jiaxin Development Company | - |
| Zhejiang Lusheng Shipen Keji Co., Ltd | China, Ningbo, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Antoxis | $411K | 16 Mar 2009 | Aberdeen, Scotland, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Antoxis | $411K | 16 Mar 2009 | Aberdeen, Scotland, United Kingdom |
